SCHEMBL8304503

SCHEMBL8304503

CC(=O)SCc1ccccc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
GAA P10253 1/20 0.51
CA12 O43570 2/20 0.50
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CA4 P22748 2/20 0.50
CA7 P43166 2/20 0.50
CA9 Q16790 2/20 0.50
LMNA P02545 1/20 0.50
FOLH1 Q04609 1/20 0.50
MAPT P10636 1/20 0.47
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 1/20 0.43
CLCN2 P51788 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9177079 0.84 AKR1C3 (0.47) ALDH1A1GAACA12CA1CA2
SCHEMBL14611610 0.84 MME (0.41) GAACA12CA1CA2CA4
SCHEMBL28191276 0.82 FOLH1 (0.56) ALDH1A1GAACA12CA1CA2
SCHEMBL4215184 0.81 ALDH1A1 (0.54) ALDH1A1GAACA12CA1CA2
SCHEMBL7076431 0.81 ALDH1A1 (0.59) ALDH1A1CA1CA2CA9LMNA
SCHEMBL28560174 0.80 ALDH1A1 (0.57) ALDH1A1GAACA12CA1CA2
SCHEMBL28653909 0.79 IDO1 (0.57) ALDH1A1GAALMNAFOLH1MAPT
SCHEMBL21964367 0.78 ALDH1A1 (0.51) ALDH1A1GAACA12CA1CA2
Bromide SCHEMBL4961580 0.77 IDO1 (0.58) ALDH1A1GAALMNAFOLH1MAPT
SCHEMBL9846353 0.77 ALDH1A1 (0.35) ALDH1A1GAACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0915843-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSES SMITHKLINE BEECHAM PLC (GB) 1999-05-19 EP disclosed
WO-1997041098-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-11-06 WO disclosed